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Background:  Aquafol, a microemulsion propofol, causes more severe and frequent pain on injection than propofol. 
The purpose of this study was to compare a combination of lidocaine and ketamine on aquafol-induced pain with 
lidocaine or ketamine alone during the induction of anesthesia.
Methods:  In this prospective, randomized, double-blinded study, 130 healthy patients who were undergoing elective 
surgery under general anesthesia were enrolled. The patients received IV lidocaine 40 mg plus ketamine 25 mg (Group 
LK, n = 43), lidocaine 40 mg (Group L, n = 42), or ketamine 25 mg (Group K, n = 45) with a rubber tourniquet on the 
forearm 1 min before the injection of microemulsion propofol. The pain score was assessed by a 4-point verbal rating 
scale (VRS) at 10 seconds after injection of microemulsion propofol 30 mg and during the injection of the remaining 
total dose. 
Results:  The incidence and severity of pain was significantly lower in Group LK than Group L or Group K at 10 
seconds after the injection of microemulsion propofol 30 mg (P < 0.05). And the incidence and severity of pain was 
significantly lower in Group LK and Group K than Group L during the injection of the remaining total dose (P < 0.05).
Conclusions:  Pretreatment with IV lidocaine 40 mg plus ketamine 25 mg with a rubber tourniquet on the forearm 1 
min before the injection of microemulsion propofol is more effective than lidocaine 40 mg or ketamine 25 mg alone 
in preventing pain from the injection of microemulsion propofol. (Korean J Anesthesiol 2010; 59: 233-237)
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Introduction
    Propofol is commonly used in the induction and maintenance 
of general anesthesia owing to its rapid onset and short duration 
of action, but propofol causes pain on injection. One method to 
reduce this pain is pretreatment with lidocaine 40 mg given with 
a tourniquet 30 sec to 120 sec before the injection of propofol [1]. 
However, even this method cannot completely prevent injection 
pain. Another method is the pretreatment with lidocaine 
together with remifentanil, alfentanil, or ketamine [2-4]. Fujii 
and Nakayama [4] stated that pretreatment with a combined 
infusion of lidocaine and ketamine is more effective in reducing 
pain on injection than lidocaine alone.
    Lipid emulsion propofol causes severe lipid solvent-related 
adverse effects, such as hypertriglyceridemia, pulmonary 
fat embolism, pancreatitis, propofol infusion syndrome, and 
drug contamination. To eliminate these problems, a hydro-
soluble lipid-free microemulsion propofol (Aquafol
Ⓡ, Daewon 
Pharmaceutical Co., Ltd, Seoul, Korea) was introduced to 
clinical practice in 2009. Although the new drug is safer, its 
pain on IV injection is much greater, so its greatest drawback in 
clinical practice is that it cannot be used alone [5,6]. The clinical 
history of microemulsion propofol is relatively short, with little 
data on how to reduce pain on injection. Therefore, we tested 
whether pretreatment with lidocaine and ketamine, which 
can prevent pain on injection of lipid-emulsion propofol, also 
prevents the pain on IV injection of microemulsion propofol. 
    We measured the pain after IV injection of microemulsion 
propofol with pretreatment with a single administration of 
either lidocaine 40 mg or ketamine 25 mg, or the combined 
administration of lidocaine 40 mg and ketamine 25 mg, to find 
the most effective method for preventing injection pain. 
Materials and Methods
    After obtaining the approval of the ethics committee and 
informed consent from patients, 130 ASA class I and II patients, 
18-70 years of age, undergoing elective surgery under general 
anesthesia were enrolled. Patients were excluded if they showed 
neurological disorders, a negative effect in communication, or 
hypersensitivity towards these drugs. 
    The patients were randomly placed into 3 groups. Before 
microemulsion propofol (Aquafol
Ⓡ, Daewon Pharmaceutical 
Co., Ltd, Seoul, Korea) was administered, Group L was pre-
treated with lidocaine 40 mg (n = 42), Group K was pretreated 
with ketamine 25 mg (n = 45), and Group LK was pretreated 
with a combination of lidocaine 40 mg and ketamine 25 mg (n = 
43). The patients were premedicated with IM midazolam 3 mg 
and glycopyrrolate 0.2 mg 30 minutes prior to surgery. Upon 
arrival in the operating room, the blood pressure, EKG, and 
oxygen saturation were monitored. An 18 G angio-catheter was 
placed in a large vein of the lower arm for the IV line. Before 
anesthetic induction, the blood pressure and heart rate were 
measured to find the baseline value. With a rubber tourniquet, 
the veins were occluded, and lidocaine and/or ketamine was 
administered, 1 min later, the tourniquet was released and 
IV microemulsion propofol 30 mg was administered; 10 sec 
later, a 4-point verbal rating scale (VRS) was used to measure 
the pain on injection. Then the remainder of the total dose 
of microemulsion propofol was administered (2 mg/kg-30 
mg), and the VRS was again measured. The nurse mixed all 
the pretreated drugs with normal saline so that they would 
be identically 3 ml, and the measurement of VRS scores was 
assessed by a blinded researcher who did not know which drugs 
were administered. When the patient fell asleep, anesthesia was 
induced with sevoflurane in oxygen and rocuronium (0.6 mg/
kg) and intubated. Anesthesia was maintained with sevoflurane 
during the surgery. 
    The VRS of the pain on injection of microemulsion propofol 
consisted of the evaluation of facial expression, withdrawal 
of the hand, tears, and pain compliants. ‘None’ was defined 
as no pain experienced. ‘Mild pain’ described patients who 
responded to feeling pain when questioned but had no facial 
grimacing and did not cry. ‘Moderate pain’ was when the 
patients had facial grimacing, withdrawal of the hand, and 
responded positively to feeling pain or complained of pain 
spontaneously. ‘Severe pain’ was when the patient voluntarily 
complained of pain, had facial grimacing, and withdrawal of 
hand (Table 1).
    Based on the bibliography references [5], the incidence rate 
of moderate to severe pain on the injection of microemulsion 
propofol was hypothesized to be 82%. After administering 
the tested drug, a reduction of moderate to severe pain on 
injection by 40% was considered clinically significant. Using 
α = 0.05 with a power 90%, the minimum sample size was 
predetermined as 40 patients per group. Statistical analysis was 
performed on SPSS (version 12.0, SPSS Inc., Chicago, IL, USA). 
The age, weight, and height of the groups were compared using 
one way ANOVA with a post-hoc Bonferroni’s test. Gender and 
Table 1. Assessment of Pain Scores of 4-point Verbal Rating Scale 
(VRS) during Injection of Microemulsion Propofol
Pain score Severity of pain
None
Mild
Moderate
Severe
No pain
Pain reported in response to questioning only, 
without any behavior signs
Pain reported in response to questioning and 
accompanied by a behavioral signs, or pain reported 
spontaneously without questioning
Strong verbal response accompanied by facial 
grimacing, withdrawal of the hand, or tears235 www.ekja.org
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the 4-point VRS were analyzed using the chi-square test. P < 0.05 
was considered statistically significant.
Results
    After assessing the pain incidence and severity after the 
injection of microemulsion propofol 30 mg, 4 patients in Group 
K and 4 patients in Group LK fell asleep before receiving the 
remaining total dose of microemulsion propofol, making it 
impossible to assess their pain. They were excluded from the 
study, leaving 122 patients in the study. There was no significant 
difference between the groups in age, gender, weight, and 
height (Table 2). 
    After the IV administration of microemulsion propofol 30 mg, 
no pain was experienced by 32 patients in Group LK, but only 
16 in Group L, and 19 in Group K. The incidence of moderate to 
severe pain was significantly lower in Group LK than Group L 
and Group K, with only 1 patient in Group LK, 7 in Group L, and 
12 in Group K (P < 0.05) (Table 3). When the remaining dose 
of microemulsion propofol was administered, there were 28 
patients in LK who experienced no pain; there were 10 patients 
in Group L; and 21 patients in Group K. Of moderate to severe 
pain, Group LK (N = 3) and Group K (N = 10) had significantly 
fewer patients than Group L (N = 22) (P < 0.05). There was no 
significant difference between Group LK and Group K (P > 0.05) 
(Table 4).
Discussion
    After venous occlusion using a tourniquet 1 minute before 
microemulsion propofol, the combined pretreatment of 
lidocaine and ketamine prevented propofol-induced pain 
better than either alone. Pain on injection is the most common 
side effect of lipid emulsion propofol, with an incidence of 
70% to 92% in adults, and may be severe [1,7]. In pediatric 
patients, it can occur in 100% of the cases [2]. Pain on injection 
can decrease when the vessel being injected into has a large 
diameter, when the infusion speed is increased, and when 
drugs are at 4
oC. Pretreatment with lidocaine, ketamine, meto-
clopramide, alfentanil, and remifentanil reduce pain incidence 
and severity [2-4, 8-10].
    Microemulsion propofol is safer because it removes the 
severe side-effects of lipid emulsion propofol, but pain severity 
is worse and it cannot be used alone [5,6]. Jung et al. [5] 
found that moderate to severe pain on injection after aquafol 
administration (microemulsion propofol) was 81.9%, and 
was 29.2% after diprivan 30 mg (lipid emulsion propofol). 
The median VAS score for microemulsion propofol (72.0) 
was 6 times as great as for lipid emulsion propofol (11.5). 
Microemulsion propofol may cause pain because it has an 
aqueous free propofol concentration that is 7 times as great 
as in lipid-emulsion propofol [6,11]. Pain may occur when 
aqueous free propofol directly stimulates the free nerve endings 
or nociceptive receptors of the myelinated A delta fibers [5,6,12]. 
Lidocaine can prevent pain on propofol injection. Lidocaine 
is not only effective as a local anesthetic effects on the vein but 
also as a stabilizer for the kinin cascade [10]. King et al. [13] 
mixed 5, 10, and 20 mg of lidocaine with lipid emulsion propofol 
and found that a greater dose reduces pain on injection. Jonson 
et al. [9] stated that lidocaine 40 mg is more effective than 20 
mg in reducing pain on injection from lipid emulsion propofol. 
The use of a tourniquet isolates the arm veins from the rest of 
the circulatory system and presents a useful model for studying 
the peripheral actions of a drug in the absence of a central effect 
[14]. Mangar and Holak [15] found that when lipid emulsion 
Table 2. Demographic Data
Group L
(n = 42)
Group K
(n = 41)
Group LK
(n = 39)
Age (yr)
Gender (M/F)
Weight (kg)
Height (cm)
44.8 ± 12.6
21/21
64.7 ± 9.4
164.6 ± 8.5
46.8 ± 16.5
22/19
62.6 ± 11.2
168.3 ± 8.2
44.1 ± 11.8
21/18
64.8 ± 13.8
163.4 ± 8.2
Values are mean ± SD. There are no significant differences among 
groups. Group L: patients pretreated with lidocaine 40 mg, Group 
K: patients pretreated with ketamine 25 mg, Group LK: patients 
pretreated with lidocaine 40 mg + ketamine 25 mg.
Table 3. 4-point Verbal Rating Scale (VRS) for Pain at 10 seconds after 
Injection of Microemulsion Propofol 30 mg
  Group L*
(n = 42)
  Group K*
(n = 41)
Group LK
(n = 39)
None
Mild 
Moderate
Severe
16 (38%)
19 (45%)
  4 (10%)
3 (7%)
19 (46%)
10 (25%)
  9 (22%)
3 (7%)
32 (82%)
  6 (15%)
1 (3%)
0 (0%)
Data are number of patients (%). Group L: patients pretreated with 
lidocaine 40 mg, Group K: patients pretreated with ketamine 25 mg, 
Group LK: patients pretreated with lidocaine 40 mg + ketamine 25 
mg. *P < 0.005 vs LK group. 
Table 4. 4-point Verbal Rating Scale (VRS) for Pain during the 
Injection of Remaining Microemulsion Propofol 
     Group L*,†
(n = 42)
Group K
(n = 41)
Group LK
(n = 39)
None
Mild 
Moderate
Severe
10 (24%)
10 (24%)
  9 (21%)
13 (31%)
21 (51%)
10 (24%)
  4 (10%)
  6 (15%)
28 (72%)
  8 (20%)
1 (3%)
2 (5%)
Data are number of patients (%). Group L: patients pretreated with 
lidocaine 40 mg, Group K: patients pretreated with ketamine 25 mg, 
Group LK: patients pretreated with lidocaine 40 mg + ketamine 25 
mg. *P < 0.001 vs LK group, 
†P < 0.05 vs K group.236 www.ekja.org
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propofol is IV administered, pretreatment with lidocaine after 
a tourniquet is inflated to 50 mmHg is more effective than not 
using a tourniquet. Picard and Tramèr [1] did a meta-analysis 
of 56 research papers and found the best way to prevent 
injecting pain from lipid emulsion propofol was first by venous 
occlusion by a rubber tourniquet, pretreating with lidocaine 40 
mg, releasing the tourniquet 30-120 sec afterwards, and then 
administering lipid emulsion propofol. Therefore, we followed 
the method suggested by Picard and Tramèr [1]: we placed a 
rubber tourniquet, pretreated with either lidocaine (40 mg) or 
ketamine or both, released the tourniquet 1 min later, and then 
administered microemulsion propofol. 
    Ketamine is an N-methyl-D-aspartate (NMDA) receptor 
antagonist and has a strong analgesic effect even at small doses. 
It effectively reduces pain on injection from lipid emulsion 
propofol, potentially via 1) central or peripheral analgesic action 
of the NMDA receptor block or 2) afferent pain pathway block 
by the peripheral local anesthesia action [16,17]. Bano et al. [18] 
believed that using a rubber tourniquet and pretreating with 
ketamine 0.5 mg/kg 1 minute before lipid emulsion propofol 
administration reduced pain on injection without causing 
hemodynamic changes. Therefore we chose ketamine 25 mg 
because it is close to 0.5 mg/kg. Fujii and Nakayama [4] found 
that the pretreatment of a mixture of lidocaine and ketamine 
significantly reduced pain on injection from lipid emulsion 
propofol more than pretreating with lidocaine alone. 
    The incidence of moderate to severe pain after administering 
microemulsion propofol 30 mg was 17% for Group L, 29% in 
Group K, and 3% in Group LK, lower than the 82% of moderate 
to severe pain on injection in the study by Jung et al. [5]. 
Lidocaine, ketamine, or the combination, therefore reduce pain 
on injection from microemulsion propofol as for lipid emulsion 
propofol. Some patients experienced no pain: 38% in Group 
L, 46% in Group K, and 82% in Group LK, indicating that the 
combination is more effective than either alone. 
    In the most studies, the initial 30 mg or 25% of the total 
propofol dose is administered to evaluate pain, because patients 
can accurately express the degree of pain at this point. However, 
in clinical practice, patients complain of greater pain when the 
remainder of the dose is infused. Therefore, we measured pain 
during both periods. The incidence of moderate to severe pain 
were increased when the remainder of the dose is infused than 
during the initial administration: 52% of the cases in Group 
L, 24% in Group K, and 8% in Group LK. Group L started with 
17% of patients with moderate to severe pain initially, but 52% 
for the remaining dose, whereas Group LK showed low levels 
during both periods. Group K also did not change during the 
administration times. Ketamine’s central effect may produce 
analgesic and sedative to block pain later in administration, 
whereas pain reduction during the initial administration is from 
a ketamine’s local effect. Eight patients that fell asleep (4 from 
both Group K and Group LK) before the remaining propofol 
was administered were removed from the study, but support 
the theory that ketamine has a central sedative effect. 
    Ketamine shows sympathetic stimulation leading to increases 
in blood pressure and heart rate. However, venous occlusion 
with a tourniquet and ketamine 0.5 mg/kg treatment reduces 
hypotension from lipid emulsion propofol during anesthetic 
induction creates hemodynamic stability [18,19]. Furuya et al. 
[20] stated that ketamine 0.5 mg/kg 1 min before lipid emulsion 
propofol injection prevented not only an excessive decrease 
prior to intubation, but also prevented any excessive increase in 
arterial pressure after intubation, and maintains hemodynamic 
stability. We will evaluate these effects in the future studies. 
    A larger dose of 2 mg/kg of ketamine alone can cause psy-
cho  mimetic emergence reactions. However, doses of 1 mg/kg 
or below used with hypnotics (such as thiopental), benzodia-
zepines, inhalation anesthetics, and opioids can prevent this 
[21-23]. Moreover, ketamine 0.5 mg/kg can also prevent pain 
when sedation or general anesthesia is induced with lipid 
emulsion propofol [24-26]. Here we show that ketamine 25 mg 
is safe as pretreatment before administering microemulsion 
propofol. 
    We did not compare lidocaine or ketamine pretreatment with 
placebo because of the ethical issues around causing severe 
pain. 
    In conclusion, a combination of lidocaine 40 mg and ketamine 
25 mg with venous occlusion using a rubber tourniquet 1 min 
before the injection of microemulsion propofol is more effective 
than lidocaine 40 mg or ketamine 25 mg alone in preventing 
pain from the injection of microemulsion propofol. 
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